Exec Chat: How Can Senzo Compete As Latecomer To COVID Testing?
Medtech Insight spoke to the CEO of Senzo, a company that has produced a highly accurate and rapid lateral flow antigen test for COVID-19, just as demand seems to be waning.
You may also be interested in...
Cyted is using Medtronic’s cytosponge collection device combined with its own analysis platform to create a simple and cheap method to screen patients for early warning signs of esophageal cancer.
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights AI trends in medtech, Exec Chats with iRhythm and medical robotics authority Moshe Shoham, and key FDA updates.
Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.